Innovative MedTech (Innovative MedTech) Days Sales Outstanding : 44.36 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Innovative MedTech Days Sales Outstanding?

Innovative MedTech's average Accounts Receivable for the three months ended in Dec. 2023 was $0.21 Mil. Innovative MedTech's Revenue for the three months ended in Dec. 2023 was $0.43 Mil. Hence, Innovative MedTech's Days Sales Outstanding for the three months ended in Dec. 2023 was 44.36.

The historical rank and industry rank for Innovative MedTech's Days Sales Outstanding or its related term are showing as below:

IMTH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 36.78 Med: 51.32 Max: 187.21
Current: 41.83

During the past 13 years, Innovative MedTech's highest Days Sales Outstanding was 187.21. The lowest was 36.78. And the median was 51.32.

IMTH's Days Sales Outstanding is ranked better than
81.93% of 808 companies
in the Medical Devices & Instruments industry
Industry Median: 64.065 vs IMTH: 41.83

Innovative MedTech's Days Sales Outstanding increased from Dec. 2022 (41.71) to Dec. 2023 (44.36).

Innovative MedTech Days Sales Outstanding Historical Data

The historical data trend for Innovative MedTech's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative MedTech Days Sales Outstanding Chart

Innovative MedTech Annual Data

Trend

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Jun20

Jun21

Jun22

Jun23

Days Sales Outstanding

Get a 7-Day Free Trial

187.21

51.32

43.48

Innovative MedTech Quarterly Data
	Oct13	Jan14	Apr14	Jul14	Oct14	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															41.71	38.74	44.39	42.68	44.36

Competitive Comparison of Innovative MedTech's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Innovative MedTech's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovative MedTech's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Innovative MedTech's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Innovative MedTech's Days Sales Outstanding falls into.

Innovative MedTech Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Innovative MedTech's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (0.186	+	0.225)	/	2 )	/	1.725	*	365
=	0.2055					/	1.725	*	365
=	43.48

Innovative MedTech's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.225	+	0.196)	/	2 )	/	0.433	*	365 / 4
=	0.2105					/	0.433	*	365 / 4
=	44.36

Innovative MedTech (OTCPK:IMTH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Innovative MedTech Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Innovative MedTech's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovative MedTech (Innovative MedTech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Innovative MedTech Inc (OTCPK:IMTH) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

2310 York Street, Suite 200, Blue Island, IL, USA, 60406

Website

https://www.innovativemedtech.com

Innovative MedTech Inc is a provider of health and wellness services. It develops, manufactures, and sells a variety of medical devices and supplies, including blood collection and infusion products, surgical instruments, and wound care products. The company operates in two divisions: the RX Vitality digital wallet and health care app.

Executives

Merle Griff	officer: Chief Executive Officer	2310 YORK ST, SUITE 200, BLUE ISLAND IL 60406
Eddie Dovner	10 percent owner	70 SE 4TH AVE, DELRAY BEACH FL 33483
Charles Everhardt	director, 10 percent owner, other: Chairman of the Board	2310 YORK ST, STE 200, BLUE ISLAND IL 60406
Arthur Friedman	10 percent owner	280 MADISON AVE #1007, NEW YORK NY 10016
Marcia Roberts	10 percent owner	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Michael Jordan Friedman	director, 10 percent owner, officer: President & CEO	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Illuminate, Inc.	10 percent owner	881 KENNEDY BLVD., JERSEY CITL NJ 07002
A William Bodine	director, officer: CFO	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Dominick M Cingari	director, officer: COO	280 MADISON AVENUE, SUITE 1005, NEW YORK NY 10016
Jay Odintz	director	280 MADISON AVENUE, NEW YORK NY 10016
Vincent L Verdiramo	director, officer: President	3163 KENNEDY BLVD, JERSEY CITY NJ 07306